The effects of iron oxide incorporation on the chondrogenic potential of three human cell types

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 6, 2013, Pages 461-469

  Saha, Sushmita ^a   Yang, Xuebin B ^a,d   Tanner, Steven ^b   Curran, Stephen ^c   Wood, David ^a   Kirkham, Jennifer ^a,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Smith and Nephew Research Centre   (United Kingdom)

^d NIHR Leeds Musculoskeletal Biomedical Research Unit   (United Kingdom)

Author keywords

Adult chondrocytes; Cell labelling; Chondrogenic potential; HBMSCs; in vitro; Neonatal chondrocytes; Superparamagnetic iron oxide

Indexed keywords

BODY FLUIDS; CARTILAGE; CELL CULTURE; CELL ENGINEERING; IRON OXIDES; MAGNETIC RESONANCE IMAGING; SUPERPARAMAGNETISM; TISSUE ENGINEERING;

ADULT CHONDROCYTE; CELL LABELLING; CHONDROCYTES; CHONDROGENIC POTENTIAL; HUMAN BONE MARROW STROMAL CELLS; IN-VITRO; IN-VIVO; NEONATAL CHONDROCYTE; SUPERPARAMAGNETIC IRON OXIDES;

CELL PROLIFERATION;

AGGRECAN; COLLAGEN TYPE 2; FERUCARBOTRAN; IRON OXIDE; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHONDROGENESIS; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TARGET CELL;

EID: 84878631651     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.544     Document Type: Article

References (56)

1. Afizah H, Yang Z, Hui JH et al. 2007; A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 13: 659-666.
2. Arbab AS, Yocum GT, Kalish H et al. 2004a; Efficient magnetic cell labelling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104: 1217-1223.
3. Arbab AS, Yocum GT, Kalish H et al. 2004b; Feride- protamine sulphate labelling does not alter differentiation of mesenchymal stem cells. Blood 104: 3412-3413.
4. Bulte JW, Kraitchman DL, MacKay GT et al. 2004; Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labelling with ferumoxides. Blood 104: 3410-3413.
5. Contag CH 2006; Molecular imaging using visible light to reveal biological changes in the brain. Neuroimaging Clin N Am 16: 633-654.
6. Chubinskaya S, Huch K, Schulze M et al. 1998; Human articular chondrocytes cultured in alginate beads maintain their gene expression. Cells and Material 8: 151-160.
7. Dodd SJ, Williams M, Suhan JP et al. 1999; Detection of single mammalian cells by high resolution magnetic resonance imaging. J Biophys 76: 103-109.
8. Dyson JA, Genever PG, Dalgarno KW et al. 2007; Development of custom-built bone scaffolds using mesenchymal stem cells and apatite-wollastonite glass-ceramics. Tissue Eng 13: 2891-901.
9. Farrell E, Wielopolski P, Pavljasevic P, et al. 2008; Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 369: 1076-1081.
10. Frank JA, Miller BR, Arbab AS et al. 2003; Clinically applicable labelling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228: 480-487.
11. Green D, Haward D, Yang XB et al. 2003; Natural marine sponge fibre skeleton: a biomimetic scaffold for human osteoprogenitor cell attachment, growth and differentiation. Tissue Eng 9: 1159-1166.
12. Green D, Walsh D, Yang XB et al. 2004; Stimulation of human bone marrow stromal cells using growth factor encapsulated calcium carbonate porous microspheres. J Mater Chem 14: 2206-2212.
13. Green D, Leveque I, Walsh D et al. 2005; Biomineralized polysaccharide capsules for encapsulation, organization, and delivery of human cell types and growth factors. Adv Funct Mater 15: 917-923.
14. Grogan SP, Barbero A, Diaz-Romero J et al. 2007; Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum 56: 586-595.
15. Hawrylak N, Ghosh P, Broadus J et al. 1993; Nuclear magnetic resonance (NMR) imaging of iron oxide labelled neural transplants. Exp Neurol 121: 181-192.
16. Hoehn M, Kustermann E, Blunk J et al. 2002; Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99: 16267-16272.
17. Hofmann M, Wollert KC, Meyer GP et al. 2005; Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
18. Huang W, Lu N, Eberspaecher H, et al. 2002; A new long form of C-Maf cooperates with Sox9 to activate the type II collagen gene J Biol Chem 277: 50668-50675.
19. Hwang WS, 1978; Ultrastructure of human foetal and neonatal hyaline cartilage. J Pathol 126: 209-214.
20. Ittrich H, Lange C, Togel F et al. 2007; In vivo magnetic resonance imaging of iron oxide labelled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 25: 1179-1191.
21. Jakob M, Demarteau O, Schafer D et al. 2001; Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81: 368-377.
22. 13C MR spectroscopy of cartilage degradation in vitro. J Magn Reson Imaging 3: 565-568.
23. Johnstone B, Hering TM, Caplan AI et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238: 265-272.
24. Josephson L, Tung CH, Moore A et al. 1999; High efficiency intracellular magnetic labelling with novel superparamagnetic-tat peptide conjugates. Bioconjug Chem 10: 186-191.
25. Kaarniranta K, Holmberg CI, Lammi MJ et al 2001; Primary chondrocytes resist hydrostatic pressure-induced stress while primary synovial cells and fibroblasts show modified HSP70 response. Osteoarthritis Cartil 9: 7-13.
26. Kircher MF, Allport JR, Graves EE et al. 2003; In vivo high resolution three-dimensional imaging of antigen specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63: 6838-6846.
27. Kostura L, Kraitchman DL, MacKay AM et al. 2004; Feridex labelling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17: 513-517.
28. Lefebvre V, Li P, De Crombrugghe B. 1998; A new long form of Sox 5 (L-Sox5), Sox 6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO 17: 5718-5733.
29. Lewin M, Carlesso N, Tung CH et al. 2000; Tat peptide derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18: 410-414.
30. Lorenzo P, Bayliss MT, Heinegard D. 1998; A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 273: 23463-23468.
31. Lutz AM, Willmann JK, Goepfert K et al. 2005; Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 237: 520-528.
32. Mailänder V, Lorenz MR, Holzapfel V et al. 2008; Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 10: 138-146.
33. Malladi P, Xu Y, Chiou M et al. 2006; Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physioll 290: C1139-C1146.
34. Malpeli M, Randazzo N, Cancedda R et al. 2004; Serum free growth medium sustains commitment of human articular chondrocyte through maintenance of Sox9 expression. Tissue Eng 10: 145-155.
35. Nakamasu K, Kawamoto T, Shen M et al. 1999; Membrane-bound transferrin-like protein (MTf): structure, evolution and selective expression during chondrogenic differentiation of mouse embryonic cells. Biochem Biophys Acta 1447: 258-264.
36. Niikura T, Reddi AH. 2007; Differential regulation of lubricin/superficial zone protein by transforming growth factor-β/bone morphogenetic protein superfamily members in articular chondrocytes and synoviocytes. Arthritis Rheum 56: 2312-2321.
37. O'Byrne E, Pellas T, Laurent D. 2003; Qualitative and quantitative in vivo assessment of articular cartilage using magnetic resonance imaging. In Tissue Engineering of Cartilage and Bone, Bock G, Goode J (eds), Novartis Foundation Symposium 249. Wiley: Chichester.
38. Oda R, Suardita K, Fujimoto K et al. 2003; Anti-membrane-bound transferrin-like protein antibodies induce cell-shape change and chondrocyte differentiation in the presence or absence of concanavalin A. J Cell Sci 116: 2029-2038.
39. Partridge K, Yang XB, Clarke NMP et al. 2002; Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 292: 144-152.
40. Reimer P, Balzer T. 2003; Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13: 1266-1276.
41. Rink T, Bartel H, Jung G et al. 1994; Effects of polycations on ion channels formed by neutral and negatively charged alamethicins. Eur Biphys J 23: 155-165.
42. Saha S, Kirkham J, Wood D et al. 2010; Comparative study of the chondrogenic potential of human bone marrow stromal cells, neonatal chondrocytes and adult chondrocytes. Biochem Biophys Res Commun 401: 333-338.
43. Sawatzky DA, Foster R, Seed MP et al. 2005; Heat-shock proteins and their role in chondrocyte protection, an application for autologous transplantation. Inflammopharmacology 12: 569-589.
44. Scarff M, Arnold SA, Harvey LM, et al. 2006; Near infrared spectroscopy for bioprocess monitoring and control: current status and future trends. Crit Rev Biotechnol 26: 17-39.
45. Schäfer R, Kehlbach R, Müller M et al. 2009; Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 11: 68-78.
46. Schett G, Redlinch K, Xu Q et al 1998; Enhanced expression of heat shock protein 70 (HSP70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. J Clin Invest 102: 302-311.
47. Stark DD, Weissleder D, Elizondo G et al. 1988; Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168: 297-301.
48. Thorne SH, Negrin RS, Contag CH. 2006; Synergistic antitumor effects of immune cell-viral biotherapy. Science 311: 1780-1784.
49. Tsuda M, Takahashi S, Takahashi Y et al. 2003; Transcriptional Co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278: 27224-27229.
50. Vogl TJ, Hammerstingl R, Schwarz W et al. 1996; Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31: 696-708.
51. Weissleder R. 1994; Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 193: 593-595.
52. Wersebe A, Wiskirchen J, Decker U et al. 2006; Comparison of gadolinium-BOPTA and ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient. Invest Radiol 41: 264-271.
53. Winrow YR, McLean L, Morris CJ, et al. 1990; The heat shock protein response and its role in inflammatory disease. Ann Rheum Dis 49: 128-132.
54. Yang XB, Webb D, Blaker J et al. 2006; Evaluation of human bone marrow stromal cell growth on biodegradable polymer/Bioglass® composites. Biochem Biophys Res Commun 342: 1098-1107.
55. Yano S, Kuroda S, Shichinohe H et al. 2005; Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? A double labeling study. Brain Res 1065: 60-67.
56. Yeh TC, Zhang W, Ildstad ST et al. 1995; In vivo dynamic MRI tracking of rat T-cells labelled with superparamagnetic iron oxide particles. Magn Reson Med 33: 200-208.